Press Releases and Statements

Washington, D.C. – The Consumer Healthcare Products Association (CHPA) today released the below statement following the announcement that the U.S. Food and Drug Administration (FDA) approved its reorganization efforts involving the creation of a unified Human Foods Program (HFP), adoption of a new model for its field operations, and other significant modernization efforts:

CHPA released the below statement today following Governor Phil Scott signing S. 187 into law this week, legislation that will allow students to carry and self-apply sunscreen at school with the permission of a parent or guardian.

CHPA released the below statement today following Tennessee Governor Bill Lee's recent signing of Senate Bill 2048 into law, legislation that raises the monthly purchase limit for common over-the-counter (OTC) cold and allergy medications containing the ingredient pseudoephedrine (PSE) from 5.76 grams per month to 7.2 grams, allowing access to a full 30-day supply per month. The bill also raises the annual purchase limit to 43.2 grams, which is a 40% increase from the current limit of 28.8 grams.

CHPA Response to Study Published in Neurology Clinical Practice, Examining Prescription Acid Reflux Drugs:

(WASHINGTON, DC) – The Health In Hand Foundation today announced the call for nominations for its 2024 U.S. Self-Care Marketing Awards. Winners will be announced at the ninth annual Health In Hand Foundation Gala on Nov. 13 at The Bellevue Hotel in Philadelphia.

(WASHINGTON, D.C.) – Representatives from the Consumer Healthcare Products Association (CHPA), Sanofi Consumer Healthcare, Haleon, Kenvue, and Bayer participated in a discussion this week hosted by U.S. Rep. Bob Latta (OH-05) to provide an analysis of the over-the-counter (OTC) Monograph Drug User Fee Program (OMUFA), how some OTCs come to market through the Rx-to-OTC-switch process, how these products are regulated by the U.S. Food and Drug Administration (FDA), and industry’s efforts to expand HSA/FSA coverage for dietary supplements and oral care products.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) today announced the appointment of Michael A. Bailey to serve as its new Senior Vice President of Regulatory & Scientific Affairs. Having nearly four decades of extensive scientific and regulatory affairs experience at leading healthcare companies, Bailey will bring a diverse wealth of knowledge and expertise to CHPA’s regulatory department. He will officially begin his work at CHPA on April 15, 2024. Bailey will report to CHPA President and CEO Scott Melville and will be a member of the association’s senior management team.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the below statement today following the adoption of Kentucky House Bill 386 into law, legislation that will eliminate the state’s annual purchase limit for common over-the-counter (OTC) cold and allergy medications containing the ingredient pseudoephedrine (PSE), which is currently the most restrictive yearly limit nationwide at 24 grams, or roughly a three-month supply.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association released the following statement today in response to draft guidance released from the U.S. Food and Drug Administration (FDA) on New Dietary Ingredient Notification (NDIN) Master Files for Dietary Supplements:

(AMELIA ISLAND, Fla.) – The Consumer Healthcare Products Association (CHPA) and its 501c3 educational arm – the Health In Hand Foundation – today announced the election of new board members to both organizations during the association’s annual Self-Care Leadership Summit (SLS) in Amelia Island, Florida this week.

(AMELIA ISLAND, Fla.) – The Consumer Healthcare Products Association (CHPA) awarded its Ivan D. Combe Lifetime Achievement Award to longtime industry leader Jeff Needham at the opening session of its annual Self-Care Leadership Summit (SLS) today in Florida. The Combe Award is the highest honor bestowed by the U.S. consumer healthcare industry, which recognizes the outstanding work and contributions of individuals whose lifetime of achievements have created a lasting impact on the industry, their community, and have directly improved self-care for consumers.

(WASHINGTON, D.C.) – Consumer Healthcare Products Association President and CEO Scott Melville released the below statement today in response to a letter from U.S. Senator Dick Durbin (D-IL) calling for modernization of the Dietary Supplement Health and Education Act (DSHEA) following the recent death of an Ohio man who ingested tianeptine, which is not an over-the-counter (OTC) medicine nor a dietary supplement, but an adulterant used by bad actors falsely marketing products as dietary supplements: